Skip to main content
. 2001 Feb 27;98(5):2598–2603. doi: 10.1073/pnas.051630998

Table 1.

In vivo growth of PPARδ null cells

Experiment no. Frequency All tumors Established tumors
1 (28 days)
 PPARδ +/+ 2/2 1218  ± 1095 1218  ± 1095
 PPARδ +/− 2/2 987  ± 49 987  ± 49
 PPARδ −/− clone 1 1/2 2  ± 2 4  ± NA
2 (30 days)
 PPARδ +/+ 4/4 1306  ± 680 1306  ± 680
 PPARδ +/− 4/4 2333  ± 803 2333  ± 803
 PPARδ −/− clone 1 4/4 374  ± 46 374  ± 46
3 (33 days)
 PPARδ +/+ 10/10 1617  ± 248 1617  ± 248
 PPARδ −/− clone 1 4/10 271  ± 107 609  ± 90
4 (34 days)
 PPARδ +/+ 5/5 1922  ± 823 1922  ± 823
 PPARδ −/− clone 2 2/5 86  ± 64 214  ± 115
5 (34 days)
 PPARδ +/+ 6/6 673  ± 80 673  ± 80
 PPARδ +/− 5/5 732  ± 164 732  ± 164
 PPARδ −/− clone 1 2/5 56  ± 48 141  ± 66
 PPARδ −/− clone 2 1/5 49  ± 49 243  ± NA

In vivo growth of PPARδ null cells. Five experiments are presented measuring the growth of various PPARδ null lines as described in Materials and Methods. The Frequency column indicates the fraction of inoculation sites in which a tumor grew. The All tumors column indicates the average volume (mm3) ±SE of tumors for all inoculation sites, whereas the Established tumors column indicates the average volume (mm3) ±SE for only those tumors that were clearly detectable on the date of the final measurement, as indicated in parentheses next to the experiment number. NA, not applicable.